Matthew R. Porembka

A STING-activating nanovaccine for cancer immunotherapy

Min Luo, Hua Wang, Zhaohui Wang et al. · Nature Nanotechnology · 2017 · 859 citations · Full text

Nanomedicine, Sting-activating Nanovaccine, Immunology +5

Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis

Ali A. Mokdad, Rebecca M. Minter, Hong Zhu et al. · Journal of Clinical Oncology · 2016 · 393 citations

Neoadjuvant Therapy Followed, Surgical Oncology, Pancreatic Cancer +13

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth

Matthew R. Porembka, Jonathan B. Mitchem, Brian A. Belt et al. · Cancer Immunology Immunotherapy · 2012 · 276 citations

Tumor Biology, Pancreatic Cancer, Medicine +10

Quantitative Weighting of Postoperative Complications Based on the Accordion Severity Grading System: Demonstration of Potential Impact Using the American College of Surgeons National Surgical Quality Improvement Program

Matthew R. Porembka, Bruce L. Hall, Mitzi Hirbe et al. · Journal of the American College of Surgeons · 2010 · 173 citations

Induction of Th17 Cells in the Tumor Microenvironment Improves Survival in a Murine Model of Pancreatic Cancer

Jennifer L. Gnerlich, Jonathan B. Mitchem, Joshua Weir et al. · The Journal of Immunology · 2010 · 129 citations · Full text